Neogen (NEOG) analyst forecast and price target
Analyst forecast
Consensus of 5 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Piper Sandler | Upgraded | Neutral → Overweight | $14.00 from $13.00 | Aug 26, 2026 |
| Piper Sandler | Maintained | Neutral | $13.00 from $11.00 | Aug 3, 2026 |
| Piper Sandler | Maintained | Neutral | $10.00 from $6.50 | Jan 12, 2026 |
| Guggenheim | Maintained | Buy | $12.00 from $8.00 | Jan 9, 2026 |
| CJS Securities | Upgraded | Market Perform → Market Outperform | $10.00 | Dec 10, 2025 |
| Piper Sandler | Maintained | Neutral | $6.50 from $5.00 | Oct 16, 2025 |
| CJS Securities | Initiated Coverage | Market Perform | $10.00 | Sep 29, 2025 |
| William Blair | Downgraded | Outperform → Market Perform | — | Jul 29, 2025 |
| Guggenheim | Maintained | Buy | $10.00 from $13.00 | Jun 30, 2025 |
| Piper Sandler | Maintained | Neutral | $5.00 from $6.40 | Apr 22, 2025 |
| Piper Sandler | Maintained | Neutral | $6.50 from $13.00 | Apr 14, 2025 |
| Guggenheim | Maintained | Buy | $13.00 from $15.00 | Apr 10, 2025 |
| Piper Sandler | Maintained | Neutral | $13.00 from $16.50 | Jan 21, 2025 |
| Guggenheim | Initiated Coverage | Buy | $15.00 | Dec 19, 2024 |
| Piper Sandler | Maintained | Neutral | $17.50 from $17.00 | Aug 6, 2024 |
| Piper Sandler | Maintained | Neutral | $17.00 from $19.00 | Apr 15, 2024 |
| Piper Sandler | Maintained | Neutral | $19.00 from $17.50 | Jan 18, 2024 |
| Piper Sandler | Maintained | Neutral | $17.50 from $24.00 | Oct 16, 2023 |
| Wells Fargo | Maintained | Overweight | $28.00 from $22.00 | Aug 14, 2023 |
Frequently asked questions
Is NEOG a buy, sell, or hold?
Analysts covering Neogen currently average a Hold rating: 2 buy, 3 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on NEOG?
On Aug 26, 2026, Piper Sandler upgraded Neogen to Overweight with a price target of $14.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.